Laboratory Price To Sales Ratio from 2010 to 2024

LH Stock  USD 242.15  0.00  0.00%   
Laboratory's Price To Sales Ratio is decreasing with very volatile movements from year to year. Price To Sales Ratio is predicted to flatten to 1.57. Price To Sales Ratio is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing Laboratory's market cap by its total sales or revenue over a 12-month period. View All Fundamentals
 
Price To Sales Ratio  
First Reported
2010-12-31
Previous Quarter
1.6278252
Current Value
1.57
Quarterly Volatility
0.28788143
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Laboratory financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Laboratory's main balance sheet or income statement drivers, such as Interest Expense of 209.6 M, Total Revenue of 12.8 B or Gross Profit of 2 B, as well as many indicators such as Price To Sales Ratio of 1.57, Dividend Yield of 0.0122 or PTB Ratio of 3.28. Laboratory financial statements analysis is a perfect complement when working with Laboratory Valuation or Volatility modules.
  
Check out the analysis of Laboratory Correlation against competitors.

Latest Laboratory's Price To Sales Ratio Growth Pattern

Below is the plot of the Price To Sales Ratio of Laboratory of over the last few years. Price to Sales Ratio is figured by comparing Laboratory stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Laboratory sales, a figure that is much harder to manipulate than other Laboratory of multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Laboratory's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Laboratory's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 1.57 X10 Years Trend
Very volatile
   Price To Sales Ratio   
       Timeline  

Laboratory Price To Sales Ratio Regression Statistics

Arithmetic Mean1.36
Geometric Mean1.33
Coefficient Of Variation21.21
Mean Deviation0.21
Median1.24
Standard Deviation0.29
Sample Variance0.08
Range1.1961
R-Value(0.04)
Mean Square Error0.09
R-Squared0
Significance0.88
Slope(0)
Total Sum of Squares1.16

Laboratory Price To Sales Ratio History

2024 1.57
2023 1.63
2022 1.24
2021 1.62
2020 1.22
2018 0.97
2017 1.34

About Laboratory Financial Statements

Investors use fundamental indicators, such as Laboratory's Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although Laboratory's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Price To Sales Ratio 1.63  1.57 

Currently Active Assets on Macroaxis

Check out the analysis of Laboratory Correlation against competitors.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.05)
Dividend Share
2.88
Earnings Share
5.28
Revenue Per Share
151.028
Quarterly Revenue Growth
0.074
The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.